Oberland Capital Raises $1.05 Billion Healthcare Royalty Fund to Invest in Companies Advancing Products in Late-Stage Clinical Development
Oberland Capital Raises $1.05 Billion Healthcare Royalty Fund to Invest in Companies Advancing Products in Late-Stage Clinical Development
05/05/20, 10:05 AM
Location
new yorkMoney raised
$1 billion
Oberland Capital Management LLC ("Oberland Capital") announced the closing of the Oberland Capital Healthcare Solutions Fund and affiliated funds (together, the "Fund" or "Solutions Fund"), with $1.05 billion of capital commitments at the Fund's hard cap. The Solutions Fund will provide capital to biopharmaceutical, diagnostic and medical device companies advancing products in late-stage clinical development or under review by regulatory authorities in exchange for royalties on the products once approved and commercialized.
Company Info
Location
new york, new york, united states
Additional Info
Oberland Capital, a private investment firm with over $2.25 billion in capital commitments since inception, is focused exclusively on investing in the global healthcare industry and specializes in flexible investment structures customized to meet the specific capital requirements and strategic objectives of its transaction partners. Oberland Capital's broad suite of financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, and investments in traditional debt and equity. With a combination of deep industry knowledge and extensive structured finance experience, the Oberland Capital team has a history of creating value for its transaction partners. The firm was founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein.